Switching intravitreal anti-VEGF treatment in neovascular age-related macular degeneration

European journal of ophthalmology

Volumn 25, Issue 1, 2015, Pages 51-56

  Küçükerdönmez, Cem ^a   Gelisken, Faik ^a   Yoeruek, Efdal ^a   Bartz Schmidt, Karl U lrich ^a   Leitritz, Martin A lexander ^a  

^a IZMIR UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; BEVACIZUMAB; MONOCLONAL ANTIBODY; RANIBIZUMAB; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

AGED; ANTAGONISTS AND INHIBITORS; COMPARATIVE STUDY; DRUG SUBSTITUTION; FEMALE; HUMAN; MALE; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; VERY ELDERLY; VISUAL ACUITY; WET MACULAR DEGENERATION;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; DRUG SUBSTITUTION; FEMALE; HUMANS; MALE; PROGNOSIS; RETROSPECTIVE STUDIES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; WET MACULAR DEGENERATION;

EID: 84922480002     PISSN: None     EISSN: 17246016     Source Type: Journal    
DOI: 10.5301/ejo.5000480     Document Type: Article

References (0)